MedTrace Logo

VitalScan MCG Rule-out Multi-centre Pivotal Study - US

NCT03546933 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 651

Last updated 2019-09-18

No results posted yet for this study

Summary

A prospective multi-centre observational study to validate the diagnostic accuracy of a transportable magnetocardiograph device for acute coronary syndrome (ACS), focusing on rule-out capability, in patients who present to the emergency department with chest pain symptoms consistent with ACS.

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

VitalScan Magnetocardiograph

A passive, non-contact, mobile medical device that measures, displays, stores, and retrieves magnetic fluctuations caused by heart activity at a patient's bedside.

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • Creavo Medical Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Gregory J Fermann, MD · University of Cincinnati

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-17
Primary Completion
2019-08-06
Completion
2019-08-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03546933 on ClinicalTrials.gov